Related Experiment Videos
Liposomal drug delivery systems--clinical applications
Parveen Goyal1, Kumud Goyal, Sengodan Gurusamy Vijaya Kumar
1Department of Pharmaceutics, Lord Shiva College of Pharmacy, Near Civil Hospital, Post Box No. 63 Sirsa-125055, Haryana, India. parveenlscp@yahoo.com
Acta Pharmaceutica (Zagreb, Croatia)
|May 24, 2005
Summary
Liposomes are advanced drug carriers improving therapeutic delivery for diseases like cancer and infections. Ongoing research enhances their targeting capabilities for clinical applications.
Area of Science:
- Biomedical Engineering
- Pharmaceutics
- Nanotechnology
Background:
- Liposomes have been researched since the 1970s as drug delivery systems.
- Significant advancements have made liposome technology clinically relevant for treating diseases.
- Commercial and clinical trial liposome formulations demonstrate their therapeutic success.
Purpose of the Study:
- To review progress in liposomal drug delivery for key diseases.
- To highlight the integration of clinical insights into liposome design.
- To discuss applications in cancer, antibacterial, and antifungal treatments.
Main Methods:
- Review of scientific literature on liposomal drug delivery.
- Analysis of lipid-drug interactions and liposome disposition.
- Evaluation of targeted delivery strategies and gene transfer.
Main Results:
- Liposome technology has evolved significantly for targeted drug delivery.
- Successful clinical applications exist for cancer, bacterial, and fungal infections.
- Targeted liposome design can enhance efficacy in specific tissues and cells.
Conclusions:
- Liposomal drug delivery systems offer promising therapeutic potential.
- Understanding lipid-drug interactions and disposition is crucial for formulation.
- Future applications include enhanced gene therapy and targeted disease treatment.